Jun / 2026Hearing News WatchAcousia Reports Promising First-in-Patient Phase 2a Results for ACOU085 in Cisplatin-Induced Ototoxicity HHTMJun / 2026Hearing TechnologiesO2 and Mavenir Trial Network Technology to Improve Call Clarity for People with Hearing Loss HHTMJun / 2026Better Hearing ConsumerTips for Presenting on Hearing Loss: Part 2 Gael HannanJun / 2026This Week in HearingNew Study Evaluates Nuance Audio Glasses: Can They Improve Speech in Noise? HHTMFind HearingMay 22, 2026 Hearing Loss Is a Family Matter: What Audiologists Should Know HHTMHearing EconomicsMay 14, 2026 Ear device patents for March 2026 Holly Hosford-DunnHear in Private PracticeJune 4, 2026 Brian Taylor Has An Ear to the Ground HHTMDizziness DepotJune 11, 2026 Vestibular Neuritis- Recovery vs. Compensation Brady WorkmanHear The MusicJune 11, 2026 Digital Delay…Once Again: Why a Solved Problem May Not Be Solved After All Marshall ChasinPathways Society April 7, 2026 April 2026 NeuroAudiology Newsletter HHTMTinnitus Education CornerJune 10, 2026 From Reaction to Response: Changing Our Relationship with Tinnitus HHTMHearing TechnologyJune 12, 2026 O2 and Mavenir Trial Network Technology to Improve Call Clarity for People with Hearing Loss HHTMHearing News WatchJune 12, 2026 Acousia Reports Promising First-in-Patient Phase 2a Results for ACOU085 in Cisplatin-Induced Ototoxicity HHTM
Jun / 2026Hearing News WatchAcousia Reports Promising First-in-Patient Phase 2a Results for ACOU085 in Cisplatin-Induced Ototoxicity HHTM
Jun / 2026Hearing TechnologiesO2 and Mavenir Trial Network Technology to Improve Call Clarity for People with Hearing Loss HHTM
Jun / 2026This Week in HearingNew Study Evaluates Nuance Audio Glasses: Can They Improve Speech in Noise? HHTM
June 11, 2026 Digital Delay…Once Again: Why a Solved Problem May Not Be Solved After All Marshall Chasin
June 12, 2026 O2 and Mavenir Trial Network Technology to Improve Call Clarity for People with Hearing Loss HHTM
June 12, 2026 Acousia Reports Promising First-in-Patient Phase 2a Results for ACOU085 in Cisplatin-Induced Ototoxicity HHTM
